Antimicrobial Stewardship Project Newsletter

CIDRAP News: Med societies ask that HAI penalties be suspended

Warning that persistent staff and supply shortages in hard-hit hospitals during the COVID-19 pandemic have led to disruptions that could result in an increase in drug-resistant hospital infections, the heads of three US medical professional societies last week sent a letter to the Department of Health and Human Services requesting a suspension of reimbursement penalties for healthcare-associated infections.

Read more



COVID-Related Superbug Outbreak

Test your knowledge on a hospital superbug outbreak caused by COVID-related disruptions to standard infection control measures.
Resource Hub

AMR Diagnostics Resources

Explore our resources on rapid diagnostics, antimicrobial susceptibility testing and reporting, laboratory capacity, and therapeutic guidance.

Upcoming Events and Opportunities


Call for COVID-19/AMR Research Fellow

The University of St. Andrews is accepting applications through Jan 15 for a research fellow to work on a project investigating the impact of COVID-19 on the behavioral drivers of AMR in East Africa.
Feb 10–11 Meeting


The US Department of Health and Human Services announced a meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) on Feb 10 and Feb 11.

COVID-19 and Co-infections


Global AMR Progress during the Pandemic

The World Health Organization (WHO) released a report on progress and coordination toward AMR global and national action plans over 2020, highlighting the focus on developing guidelines for appropriate antibiotic use in the context of COVID-19.

COVID-19 and Antibiotic Use Video

The Pan American Health Organization developed a short video on the connections between COVID-19, antibiotic use, and AMR.

Antimicrobial Education in an Irish Maternity Hospital

The Irish Medication Safety Network posted slides from a presentation given by Sarah Fenton, MPharm, MSc, on delivering education about new antimicrobial guidelines at an Irish maternity hospital during the pandemic.

Investment in AMR after the Pandemic

The Financial Times editorial board describes the necessity of preparing to tackle AMR after the COVID-19 pandemic, particularly in the arenas of agricultural antimicrobial use and government involvement in antimicrobial development incentives.

Scottish Stewardship Experiences during COVID-19

The Scottish Antimicrobial Prescribing Group posted presentations from a meeting on addressing current challenges in antimicrobial stewardship and antibiotic use during the COVID-19 pandemic.

Global AMR/AMS Policy and Projects


Global-PPS in Nigeria and Georgia

The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) published a newsletter about progress from 2020, specifically in Nigeria and the country of Georgia, and plans for 2021 to support Global-PPS participants in gathering AMR and antibiotic use data that can be used to inform stewardship.

Insights into the Antifungal Pipeline

On IDStewardship, Emily Fox, PharmD, highlights five things to know about the antifungal pipeline, including options for oral and parenteral outpatient therapy.
National Action Plan

Oman's AMR Action Plan

Oman's Ministry of Health and Ministry of Agriculture & Fisheries published the country's AMR National Action Plan.
Workshop Proceedings

Excellence in Sepsis Diagnosis

The US National Academies of Sciences, Engineering, and Medicine published proceedings of a workshop on achieving excellence in sepsis diagnosis.

Global One Health Risk Assessment

The World Organisation for Animal Health, the Food and Agriculture Organization of the United Nations, and the WHO published a Joint Risk Assessment Operational Tool to support countries in assessing risks, including AMR, at the human–animal–environment interface.

In the Literature

Literature Summary

Antimicrobial Prophylaxis in Blood Cancers

In Critical Reviews in Oncology/Hematology, Alessandro Busca, MD, et al present a position statement on antimicrobial use in patients with lymphoproliferative malignancies, given the relative shortage of information about infectious complications and the benefits of antimicrobial prophylaxis in this group.
Literature Summary

Nosocomial Infections in COVID-10 Patients in Spain

In the European Journal of Clinical Microbiology and Infectious Diseases, Tommaso Bardi, MD, et al found that 40.7% of 140 patients admitted to a Spanish intensive care unit with severe COVID-19 from March to May 2020 developed a nosocomial bacterial or fungal infection.
RSS Feeds

Contact Us

Center for Infectious Disease Research and Policy
Academic Health Center, University of Minnesota, Minneapolis, MN

Copyright © 2021 Regents of the University of MN
Academic Health Center, University of MN

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.